FENTANYL CITRATE
These highlights do not include all the information needed to use ORAL TRANSMUCOSAL FENTANYL CITRATE safely and effectively. See full prescribing information for ORAL TRANSMUCOSAL FENTANYL CITRATE. ORAL TRANSMUCOSAL FENTANYL CITRATE , oral transmucosal lozenge, CII Initial U.S. Approval: 1968
552ba162-76ed-4bc9-8c2c-fac7a1804da0
HUMAN PRESCRIPTION DRUG LABEL
Oct 19, 2023
SpecGx LLC
DUNS: 080679498
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
FENTANYL CITRATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
FENTANYL CITRATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
FENTANYL CITRATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
FENTANYL CITRATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
FENTANYL CITRATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
FENTANYL CITRATE
Product Details
FDA regulatory identification and product classification information